Khosla Rachna 4
4 · AMGEN INC · Filed May 7, 2024
Insider Transaction Report
Form 4
AMGEN INCAMGN
Khosla Rachna
SVP, Business Development
Transactions
- Tax Payment
Common Stock
2024-05-05$311.29/sh−41$12,763→ 8,027 total
Footnotes (2)
- [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 128 RSUs which will vest on 4/30/2025; 784 RSUs which will vest in installments of 386 on 11/5/2024 and 398 on 11/5/2025; 407 RSUs which will vest in installments of 200 on 5/2/2025, and 207 on 5/2/2026; and 593 RSUs which will vest in in installments of 195 on 5/2/2025, 196 on 5/2/2026 and 202 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 131 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.